Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Holger Müller

CEO & Co-Founder

ProVascTec

Cork, Ireland

I am the CEO of ProVascTec, a cell therapy company that combines biomedical engineering with cell therapies to enable intracorporal precision delivery of cells

My organisation

ProVascTec

ProVascTec

SME

Cork, Ireland

About me

I am the CEO and co-founder of ProVascTec. Following an education in chemistry, which concluded with a PHD from the Swiss Federal Institute of Technology, Holger started his professional career at Bain & Company, a leading international strategic management consultancy. He later joined Novartis, where he was leading several innovation projects at various stages of the product lifecycle. Following a 10 year career at Novartis, Holger joined Cell Medica as SVP Commercial Operations, a cell therapy company focused on immunological- and hematological applications. Subsequently, Holger held additional c-level positions at startup companies in Switzerland before joinging ProVascTec in 2013.

Social media

Marketplace (1)

  • Project cooperation

    Development of a biodegradable stent like scaffold

    Stents have become staples in angioplasty procedures. ProVascTec intends to develop a biodegradable stent-type scaffold for use in PVT1812

    • Early
    • Research
    • Technical
    • Healthcare
    • EU projects
    • Biotech, Pharma and Cosmetics
    • Partner looking for consortium
    Author

    Holger Müller

    CEO & Co-Founder at ProVascTec

    Cork, Ireland